MORGAN STANLEY PLC/CALL/ECKERT & ZIEGLER/57/0.1/20.09.24 Share Price

Warrant

DE000ME7UR18

Market Closed - Börse Stuttgart 11:42:11 20/06/2024 pm IST
0.105 EUR +11.70% Intraday chart for MORGAN STANLEY PLC/CALL/ECKERT & ZIEGLER/57/0.1/20.09.24
Current month-17.32%
1 month-45.03%
Date Price Change
20/24/20 0.105 +11.70%
19/24/19 0.094 -4.08%
18/24/18 0.098 -8.41%
17/24/17 0.107 +1.90%
14/24/14 0.105 -12.50%

Delayed Quote Börse Stuttgart

Last update June 20, 2024 at 11:42 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ECKERT & ZIEGLER SE
Issuer Morgan Stanley
WKN ME7UR1
ISINDE000ME7UR18
Date issued 29/01/2024
Strike 57
Maturity 20/09/2024 (92 Days)
Parity 10 : 1
Emission price 0.21
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.49
Lowest since issue 0.079
Delta0.22x
Omega 8.014
Premium28.02x
Gearing36.4x
Moneyness 0.7982
Difference Strike 11.5
Difference Strike %+20.18%
Spread 0.04
Spread %27.59%
Theoretical value 0.1250
Implied Volatility 48.50 %
Total Loss Probability 84.48 %
Intrinsic value 0.000000
Present value 0.1250
Break even 58.25 €
Theta-0.01x
Vega0.01x
Rho0x

Company Profile

Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Sector
-
More about the company

Ratings for Eckert & Ziegler SE

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eckert & Ziegler SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
45.5 EUR
Average target price
62.5 EUR
Spread / Average Target
+37.36%
Consensus